Morgans sees Regis Healthcare as oversold
Scott Power from Morgans CIMB sees recent share price weakness in Regis Healthcare (ASX: REG) as presenting a buying opportunity. The company’s shares have been sold down substantially over the last few months as a result of uncertainty within the age care services industry.
Since the start of August the company’s share price has slumped from $5.25 to hit an all-time low of $3.45 last week before staging a recovery in recent days. Thursday’s closing price of $3.91 represents a sizeable discount to Powers’ price target of $5.13.
It should be noted that analyst’s forecasts and price targets may not necessarily be met. Similarly, historical trading patterns should not be used as the basis for an investment decision as these may not be replicated in the future.
The company’s fiscal 2016 performance was impressive having grown net profit by 24%, opened up 211 new places during the period and achieved an average occupancy rate of 95.2%.
Fundamentally, the company is starting to look cheap, trading on a PE multiple of circa 18 relative to Powers’ fiscal 2017 forecasts. He is projecting compound annual earnings per share growth of approximately 27% between fiscal years 2016 and 2018.
This represents superior growth to most of the group’s peers and it is worth noting that the industry group average PE multiple based on fiscal 2017 forecasts is 28.5.
In terms of the industry environment, Powers noted that the Department of Health has provided more clarity over the charging for additional care and services in residential aged care, including capital refurbishment type fees.
It was uncertainty regarding this issue that largely impacted sentiment towards the sector in recent months.
Recent commentary from the Department of Health indicated that it considers capital refurbishment fees, asset replacement contributions and similar fees would not be supported by the legislation where the fee does not provide a direct benefit to the individual or the resident cannot take up or make use of the services, or where the activities or services subject to the fee are part of the normal operations of an aged care home and fall within the scope of specified care and services.
Powers noted that there appears to be poor communication between the government and the operators and that unconfirmed news indicates that the government may look to review the cuts that had been flagged, a development that would restore faith in the sector.
Consequently, he has not made any changes to fiscal 2017 and 2018 forecasts, but taken on a more conservative stance regarding fiscal 2019 forecasts should changes be introduced. This indicates that there is near-term earnings reliability, suggesting that the extent of the sell-off is unwarranted.
Powers summed up his stance on the overall sector saying, “We believe the underlying demand for aged places remains strong and we believe a sensible compromise will be reached between the government wanting to curtail the growth rate of expenditure and the operators who are facing residents entering their facilities with higher levels of acuity”.
From an operational perspective, fiscal 2016 yielded some promising developments, particularly in relation to the acquisition of Masonic Care Queensland which effectively added 711 operational places, increasing the group’s portfolio by 14%.
Management recently reaffirmed that the acquisition was on track to be earnings per share accretive in fiscal 2017, with the expectation that it will boost EBITDA by as much as $12 million.
Regis offers strong geographic diversification with operations in all states and territories except for Tasmania and the Australian Capital Territory. The table below demonstrates the pipeline of projects that should underpin robust growth over the next three years.
When the experts at Next Investors have a stock pick, it may pay to listen.
The Next Investors have been investing in ASX small cap stocks for years, with their best small cap picks yielding returns of 1,200%, 1,120%, 900% and 678%.
They have just revealed their hand-picked, FY2021 stock portfolio of high conviction long-term investments.
Click the link below to see what they are currently investing in.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.